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Workingfor
Women's Health
Women's health is an area that is gaining
increasing attention with the realization
that men's and women's bodies don't just
look different-they also react differently to
environmental agents. Barbara J. Davis,
head ofthe Female Reproductive Pathology
Group and now acting chief of the newly
created Laboratory of Women's Health, is
leading women's health studies at the
NIEHS. Over the course ofher 10 years at
the institute, Davis has concentrated her
efforts on studying ovarian toxicity and its
relationship to the environment.
The ramifications of infertility stretch
further than just whether a woman can bear
children. For instance, in addition to mak-
ing a woman less likely to conceive, persis-
tently lower estrogen concentrations have
been shown to contribute to osteoporosisf
and heart disease. Davis urges a broad pe
spective in looking at women's health,
perspective that takes into account not jut
the primary effects but also the secondaijr
and tertiary effects ofa particular exposure.
Davis's strategy has been to develop
rodent models that mimic the human men-
strual cycle so that she can study the effects
ofchemical exposures over several iterations
of a hormonal cycle. Rather than inundate
the model with a chemical that totally shuts
down the reproductive system, she says, she
leaves the reproductive system intact so as to
study the long-term effects of certain expo-
sures. Davis feels that the cyclical approach
taken toward women's diseases could also be
applied to male-specific hormone-related
diseases such as prostate cancer.
The Female Reproductive Pathology
Group provides support for reproductive
toxicity studies conducted by the National
Toxicology Program. The group studies the
pathophysiology of ovarian dysfunction
and cancer in women and rodents caused
by chemical exposures, and seeks to identify
ovarian target cells as well as the biochemi-
cal and molecular mechanisms by which
both synthetic and naturally occurring
environmental chemicals cause ovarian dys-
function or cancer. Both in vivo and in
vitro models are used in this work. The
group is also working to determine the role
of key genes and signaling molecules in
ovarian cell growth, differentiation, and
physiology, and to understand how to
modify these pathways to prevent or lessen
the chance ofovarian dysfunction and can-
cer. The Laboratory of Women's Health is
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The Role ofCOXs
Cyclooxygenases (COXs) are enzymes
that produce various synthases of
prostaglandins, which play a critical role
in signaling ovarian function, ovulation,
and luteal function. Along with col-
leagues in the Metabolism and Molecular
Mechanisms Group within the NIEHS
Laboratory of Environmental Carcino-
genesis and Mutagenesis, Davis conduct-
ed studies to delineate the roles of COX-
1 and COX-2 in reproductive function.
The studies, published in the June 1999
issue of Endocrinology, used mice lacking
the genes for either COX-1 or COX-2.
The investigators were able to determine
that mice that lacked COX-2 failed to ovu-
late and had abnormal implantation and
decidualization responses (the uterine
changes that allow for implantation), where-
as the COX-1-deficient mice were fertile.
The studies also showed that the COX-
1-deficient mice exhibited aberrant estradiol
production and indicated that both
prostaglandins and estradiol are necessary for
normal delivery. Finally, the studies showed
for the first time that ovulation can be
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restored in COX-2-deficient mice by simul-
taneous treatment with gonadotropins and
either the prostaglandin synthase PGE2 or
the cytokine interleukin-1P, which may pro-
vide a clue to future infertility treatments.
These studies suggest that, contrary to
traditional belief, it is COX-1 and not
COX-2 that produces the prostaglandins
that are necessary for boosting ovarian
estradiol production, and that estradiol lev-
els then determine the production of
COX-2-related prostaglandins. Future
studies will evaluate specific chemicals and
their effect on ovarian function and inter-
action with prostaglandin pathways.
Pesticide Exposures
Along with Bob Chapin ofthe Reproductive
Toxicology Group within the NIEHS
Laboratory ofToxicology, Davis has studied
the effects ofpesticide exposures on juvenile
and adult rodents. In a paper published in
the November 1997 issue of Fundamental
andApplied Toxicology, for instance, the pes-
ticide methoxychlor was shown to cause
ovarian dysfunction resulting in reduced
estrous levels offollicle-stimulating hormone
at all dosages and reduced estrous proges-
terone levels at some dosages. Davis has also
studied the effects of 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD, or dioxin),
which has been shown to promote ovarian
tumors in female rats, and nitrofurantoin, an
antibiotic used for urinary tract infections
that has been associated with ovarian cancer
in rodents, although not in humans.
Davis and colleagues are currently work-
ing to understand how TCDD causes
tumors to develop and whether women may
be at risk from these exposures. One possi-
ble connection between the rodent and real
human exposure is that the type of ovarian
tumor induced by TCDD in the rats in
Davis's experiments is the same histological
subtype as that found in one young woman
who had been exposed to dioxins during a
1976 industrial accident in Seveso, Italy.
"Because this subtype of ovarian tumor is
indeed rare and because tumors ofany kind
are rare at such a young age in women, it is
possible that the appearance ofthe tumor in
the Italian woman was related to the expo-
sure," says Davis. "It is also possible this
finding could have been a random and
unrelated event. We clearly need to investi-
gate and distinguish these possibilities."
The Laboratory ofWomen's Health
The Laboratory ofWomen's Health is part
of the institute's Environmental Diseases
and Medicine Program. Davis says it's one
of the first intramural research facilities
devoted to women's health in the NIH sys-
tem. The lab is the brainchild of Davis and
Carl Barrett, scientific director of the
NIEHS and chief of the Laboratory of
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g- Ultimately, the lab's research-
ers hope to reduce the burden
ofenvironmentally related dis-
eases in women through the
combined effort and expertise
ofgeneticists, endocrinologists,
immunologists, pathologists,
and epidemiologists.
To that end, Davis empha-
sizes the idea of a "virtual lab"
in which scientists will have
free and constantly updated
access to an ever-expanding
body ofdata and knowledge to
be used as stepping stones and
building blocks in collabora-
tive research efforts. "We need
to always be ready to evolve as
we understand new concepts,
Davis says.
Susan M. Booker
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